BetterLife Pharma Inc. announced a non-brokered private placement of 3,571,429 units at a price of CAD 0.10 per non-brokered unit for aggregate gross proceeds of CAD 357,143 on March 14, 2023. Each non-brokered unit is comprised of one common share and warrant. Each warrant entitles the holder thereof to acquire one common share at an exercise price of $0.11 (CAD 0.150480) at any time up of 60 months from the closing of the offering.

The units sold pursuant to the offering will be subject to a four month hold period pursuant to applicable Canadian securities laws.